These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6383836)

  • 21. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M; Campbell RW; Talbot RG; Murray A; Prescott LE; Julian DG
    Adv Clin Pharmacol; 1978; 16():59-70. PubMed ID: 356554
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early interruption of antiarrhythmia treatment in the acute phase of infarction complicated by ventricular arrhythmia].
    Sebbah J; Khemache A; Gryman R; Farinotti R; Guérot C; Valère PE
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):129-32. PubMed ID: 4004087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
    Mehta J; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mexiletin for treatment of ventricular ectopic rhythm in patients with acute myocardial infarction (author's transl)].
    Merx W; Franken G; Brunner H; Effert S; Henning B
    Z Kardiol; 1980 Apr; 69(4):262-7. PubMed ID: 7006236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Talbot RG; Dolder M; Prescott L; Julian DG
    Br Heart J; 1975 Jul; 37(7):779. PubMed ID: 1156488
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Pantridge JF; Adgey AA
    Br Heart J; 1978 Jul; 40(7):796-801. PubMed ID: 687477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction.
    Denniss AR; Ross DL; Cody DV; Russell PA; Young AA; Richards DA; Uther JB
    Eur Heart J; 1988 Jul; 9(7):746-57. PubMed ID: 3169044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine.
    Upward JW; Holt DW; Jackson G
    Eur Heart J; 1984 Mar; 5(3):247-52. PubMed ID: 6723694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness and safety of cimetidine in patients receiving mexiletine for ventricular arrhythmia.
    Klein AL; Sami MH
    Am Heart J; 1985 Jun; 109(6):1281-6. PubMed ID: 3890504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH; Chiale PA; Bandieri JD; Lázzari JO; Elizari MV; Rosenbaum MB
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic use of mexiletine in the elderly with acute myocardial infarction.
    Datta-Chaudhari ML; O'Brien TD
    J Assoc Physicians India; 1990 Feb; 38(2):144-7. PubMed ID: 2199424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction.
    Walker LJ; MacKenzie G; Adgey AA
    Eur Heart J; 1988 May; 9(5):471-8. PubMed ID: 3042398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias.
    Rutledge JC; Harris F; Amsterdam EA
    J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the plasma concentrations and efficacy of mexiletine and of a slow-release preparation of mexiletine in patients admitted to a coronary care unit.
    Boyle DM; Barber JM; Chapman C; Khalid I; Kinney CD; McIlmoyle EL; Salathia K; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):174-9. PubMed ID: 6175798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.